Rescuing the Failing Heart by Targeted Gene Transfer

Rescuing the Failing Heart by Targeted Gene Transfer Congestive heart failure is a major cause of morbidity and mortality in the United States. Although progress in conventional treatments is making steady and incremental gains to decrease heart failure mortality, there is a critical need to explore new therapeutic approaches. Gene therapy was initially applied in the clinical setting for inherited monogenic disorders. It is now apparent that gene therapy has broader potential that also includes acquired polygenic diseases, such as congestive heart failure. Recent advances in understanding of the molecular basis of myocardial dysfunction, together with the evolution of increasingly efficient gene transfer technology, have placed heart failure within the reach of gene-based therapy. Furthermore, the recent successful and safe completion of a phase 2 trial targeting the sarcoplasmic reticulum Ca 2+ ATPase pump along with the start of more recent phase 1 trials are ushering in a new era of gene therapy for the treatment of heart failure. Journal of the American College of Cardiology Elsevier

Rescuing the Failing Heart by Targeted Gene Transfer

Loading next page...
Copyright © 2011 American College of Cardiology Foundation
Publisher site
See Article on Publisher Site


  • A combinatorial polymer library approach yields insight into nonviral gene delivery
    Green, J.J.; Langer, R.; Anderson, D.G.
  • The discovery of zinc fingers and their applications in gene regulation and genome manipulation
    Klug, A.
  • Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure
    Kawase, Y.; Ly, H.Q.; Prunier, F.
  • Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals
    Kaye, D.M.; Preovolos, A.; Marshall, T.
  • Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins
    Boekstegers, P.; von Degenfeld, G.; Giehrl, W.
  • Cardiac gene delivery with cardiopulmonary bypass
    Davidson, M.J.; Jones, J.M.; Emani, S.M.
  • Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency
    Wilson, J.M.
  • Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
    Raper, S.E.; Chirmule, N.; Lee, F.S.
  • Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
    Hajjar, R.J.; Zsebo, K.; Deckelbaum, L.
  • Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial
    Jaski, B.E.; Jessup, M.L.; Mancini, D.M.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial